Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (LXEO) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 58 transactions totaling $14.1M, demonstrating a bullish sentiment with $10.9M in net insider flow. The most recent transaction on Feb 18, 2026 involved a sale of 10,173 shares valued at $64.9K.
LXEO Insider Activity Summary
Who Is Buying LXEO Stock?
No significant insider buying has been recorded for LXEO in the recent period.
Who Is Selling LXEO Stock?
No significant insider selling has been recorded for LXEO in the recent period.
Is Lexeo Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LXEO is bullish with an Insider Alignment Score of 89/100 and a net flow of $10.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
LXEO Frequently Asked Questions
Understanding LXEO Insider Activity
Insider trading at Lexeo Therapeutics, Inc. (LXEO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading LXEO stock, having executed 58 transactions in the past 90 days. The most active insider is Venture Partners Iv, L.p. Longitude (Executive), who has made 3 transactions totaling $5.0M.
Related Tools
Track Lexeo Therapeutics, Inc. Insider Activity
Get notified when executives and directors at LXEO file new Form 4 transactions